DK166754B1 - Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid - Google Patents

Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid Download PDF

Info

Publication number
DK166754B1
DK166754B1 DK116687A DK116687A DK166754B1 DK 166754 B1 DK166754 B1 DK 166754B1 DK 116687 A DK116687 A DK 116687A DK 116687 A DK116687 A DK 116687A DK 166754 B1 DK166754 B1 DK 166754B1
Authority
DK
Denmark
Prior art keywords
dihydroxy
dihydrochloride
bis
hydroxyethylamino
ethylaminoaa
Prior art date
Application number
DK116687A
Other languages
Danish (da)
English (en)
Other versions
DK116687A (da
DK116687D0 (da
Inventor
Pradeep V Niphadkar
Narendra R Desai
Paul N Jones
Kieran G Mooney
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK116687D0 publication Critical patent/DK116687D0/da
Publication of DK116687A publication Critical patent/DK116687A/da
Application granted granted Critical
Publication of DK166754B1 publication Critical patent/DK166754B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DK116687A 1986-03-07 1987-03-06 Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid DK166754B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83724386A 1986-03-07 1986-03-07
US83724386 1986-03-07

Publications (3)

Publication Number Publication Date
DK116687D0 DK116687D0 (da) 1987-03-06
DK116687A DK116687A (da) 1987-09-08
DK166754B1 true DK166754B1 (da) 1993-07-12

Family

ID=25273922

Family Applications (1)

Application Number Title Priority Date Filing Date
DK116687A DK166754B1 (da) 1986-03-07 1987-03-06 Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid

Country Status (21)

Country Link
EP (1) EP0236822B1 (xx)
JP (1) JPH0717500B2 (xx)
KR (1) KR900002030B1 (xx)
AT (1) ATE59290T1 (xx)
AU (1) AU593330B2 (xx)
CA (1) CA1283607C (xx)
DE (1) DE3766984D1 (xx)
DK (1) DK166754B1 (xx)
ES (1) ES2033247T3 (xx)
FI (1) FI84977C (xx)
GR (1) GR3001503T3 (xx)
HK (1) HK63991A (xx)
HU (1) HU199286B (xx)
IE (1) IE60025B1 (xx)
IL (1) IL81681A (xx)
NO (1) NO173635C (xx)
NZ (1) NZ219454A (xx)
PH (1) PH22808A (xx)
PT (1) PT84398B (xx)
SG (1) SG45292G (xx)
ZA (1) ZA871652B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705601B1 (de) * 1994-10-04 2000-01-19 LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik Lösungen von Anthrachinonen zur parenteralen Applikation
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
JP5538568B2 (ja) * 2010-12-09 2014-07-02 丸石製薬株式会社 アセトアミノフェンの安定化剤
CN114601791B (zh) * 2020-12-08 2023-09-19 成都倍特药业股份有限公司 一种盐酸米托蒽醌液体制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
EP0154117B1 (en) * 1984-02-27 1989-12-27 American Cyanamid Company Use of 1,4 bis(substituted) anthrachinones for the manufacture of immunosuppresiva

Also Published As

Publication number Publication date
ZA871652B (en) 1987-08-28
DK116687A (da) 1987-09-08
GR3001503T3 (en) 1992-11-23
AU593330B2 (en) 1990-02-08
CA1283607C (en) 1991-04-30
NO870950L (no) 1987-09-08
AU6977387A (en) 1987-09-10
IL81681A (en) 1991-01-31
IE60025B1 (en) 1994-05-18
FI84977C (fi) 1992-02-25
NO870950D0 (no) 1987-03-06
ES2033247T3 (es) 1993-03-16
FI870994A (fi) 1987-09-08
NZ219454A (en) 1989-04-26
EP0236822A2 (en) 1987-09-16
EP0236822A3 (en) 1989-01-11
PT84398A (en) 1987-04-01
DE3766984D1 (de) 1991-02-07
IE870569L (en) 1987-09-07
KR870008581A (ko) 1987-10-19
HU199286B (en) 1990-02-28
EP0236822B1 (en) 1990-12-27
JPH0717500B2 (ja) 1995-03-01
JPS62265220A (ja) 1987-11-18
PH22808A (en) 1988-12-27
PT84398B (pt) 1989-10-04
FI870994A0 (fi) 1987-03-06
ATE59290T1 (de) 1991-01-15
DK116687D0 (da) 1987-03-06
SG45292G (en) 1992-06-12
FI84977B (fi) 1991-11-15
HK63991A (en) 1991-08-23
IL81681A0 (en) 1987-09-16
NO173635C (no) 1994-01-12
HUT47020A (en) 1989-01-30
NO173635B (no) 1993-10-04
KR900002030B1 (ko) 1990-03-31

Similar Documents

Publication Publication Date Title
SA08290240B1 (ar) مستحضرات دوائية تحتوي على مشتقات حمض ليبويك
JPS63104931A (ja) 酸化に対して安定化された薬剤組成物
US4871742A (en) Process and pharmaceutical compositions for the treatment of glaucoma
AU627041B2 (en) Improved nutritional formulation for the treatment of renal disease
DK161668B (da) Anvendelse af phenyleddikesyrederivater til fremstillingen af et farmaceutisk middel til behandling af eller forebyggelse mod oejenbetaendelse
IE58450B1 (en) Basic formulations of quinolonecarboxylic acids
DK166754B1 (da) Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid
EP0467856A3 (en) Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases
US3966905A (en) Stabilized catechol amine solutions
MXPA02000849A (es) Composicion oftalmica que comprende cetotifeno.
TWI277417B (en) Blood lipid ameliorant compostion
CA2477773C (en) A stable diclofenac-tromethamine composition for the topical treatment of oropharyngeal cavity disorders
US6048540A (en) Acetamenophen composition with reduced liver toxicity
WO1993006726A1 (en) Methods for treatment of free-radical-mediated tissue injury
JPS6351341A (ja) アズレン含有液剤
Stine et al. N-(2, 3-dimercaptopropyl) phthalamidic acid: protection, in vivo and in vitro, against arsenic intoxication
BR0002265A (pt) Inibidores da metaloprotease, um processo para seu preparo e composições farmacêuticas contendo os mesmos
US6034126A (en) Method for treating glycol poisoning
BR9707303A (pt) Agentes terapêuticos para asma
HUT64354A (en) Process for preparing vanady-complexes of hydroxamate chelate producing agents and pharmaceutical preparatives containing said compounds
KR910004192A (ko) 프로페니토인의 치료적 유효량을 함유하는 발작증 치료용 제약 조성물
CH666183A5 (it) Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
JPH107570A (ja) パーキンソン病予防・治療剤
MXPA00010224A (en) Stable mitoxantron solutions
WO2015092788A1 (en) Compositions comprising lipophilic diesters of chelating agents non-covalently associated with organic amines

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired